Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields
Portfolio Pulse from Avi Kapoor
Wall Street's most accurate analysts have provided their ratings on three high-yielding health care stocks: Gilead Sciences, CVS Health, and Johnson & Johnson. These stocks offer dividend yields over 3% and have received mixed ratings from analysts.
June 28, 2024 | 11:30 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
CVS Health has a dividend yield of 4.56%. Analysts from JP Morgan and Argus Research have given it Overweight and Buy ratings but have cut price targets to $86 and $80, respectively. Recent news includes first-quarter sales of $88.4 billion, missing consensus.
The downward revision of price targets and missed sales consensus suggest a negative short-term impact on CVS's stock price despite the high dividend yield.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100
NEUTRAL IMPACT
Gilead Sciences has a dividend yield of 4.47%. Analysts from Baird and RBC Capital have given it Neutral and Sector Perform ratings with price targets of $80 and $74, respectively. Recent news includes Phase 3 PURPOSE 1 Trial results.
The mixed analyst ratings and recent trial results suggest a neutral short-term impact on GILD's stock price. The high dividend yield remains attractive to investors.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Johnson & Johnson has a dividend yield of 3.40%. Analysts from Cantor Fitzgerald and B of A Securities have given it Overweight and Neutral ratings with price targets of $215 and $170, respectively. Recent news includes the acquisition of Proteologix, Inc.
The acquisition of Proteologix, Inc. and the Overweight rating from a top analyst suggest a positive short-term impact on JNJ's stock price. The high dividend yield adds to its attractiveness.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100